Carnexiv FDA Approval History
FDA Approved: Yes (Discontinued) (First approved October 7, 2016)
Brand name: Carnexiv
Generic name: carbamazepine
Dosage form: Injection
Company: Lundbeck Inc.
Treatment for: Seizures
Marketing Status: Discontinued
Carnexiv (carbamazepine) is an intravenous injection formulation of the antiepileptic drug carbamazepine indicated as short-term replacement therapy for oral carbamazepine when oral administration is temporarily not feasible.
Development timeline for Carnexiv
|Oct 7, 2016||Approval FDA Approves Carnexiv (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types|
|Apr 22, 2016||FDA Accepts Lundbeck Resubmission of New Drug Application for Carnexiv (carbamazepine)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.